US Economy U.S. News

More

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    Please choose a subscription

    Please enter a valid email address
    Get these newsletters delivered to your inbox, and more info about about our products and service. Privacy Policy.

Don't Miss

U.S. Video

  • The VC case for drug pricing

    James Thornton, venture capital investor, discusses Mylan CEO Heather Bresch's explanation for the pricing of the EpiPen. CNBC Contributor Bill George, former CEO of Medtronic, and Darnisha Harrison, Ennaid Therapeutics CEO, weigh in.

  • Ennaid CEO on cutting through the FDA's red tape

    CNBC Contributor Bill George, former CEO of Medtronic, and Darnisha Harrison, Ennaid Therapeutics CEO, discuss the controversy surrounding Mylan's pricing of the EpiPen and the FDA's guidelines for drug development.

  • How will the markets react to Yellen?

    Looking at the markets ahead of Fed Chair Janet Yellen's remarks at the Jackson Hole symposium. With CNBC's Jackie DeAngelis and the "Futures Now" traders Bob Iaccino, Path Trading Partners, and Scott Nations, NationsShares.